Overview

Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety of the tumor-specific TCR-T cells in the treatment of advanced Solid Tumor . The secondary purpose of this study is to preliminarily showed the effect of TCR-T cells in the treatment of advanced Solid Tumor .
Phase:
Phase 1
Details
Lead Sponsor:
Guangzhou FineImmune Biotechnology Co., LTD.
Collaborator:
Sun Yat-sen University
Treatments:
Interleukin-2